PRR13 and neoplasm: PRR13 expression was strongly associated with OS duration in patients in the T3, N1-3 and grade 2–3 subgroups, but not in patients in the T1-2, N0 and grade 1 subgroups, suggesting that PRR13 may play a more important prognostic role in patients with more aggressive tumour behaviour.